淋巴水肿的病理生理学——药物治疗是否可行？
Pathophysiology of lymphedema-Is there a chance for medication treatment?
作者信息
Hespe Geoffrey E, Nores Gabriela Garcia, Huang Jung-Ju, Mehrara Babak J
机构信息
Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Division of Reconstructive Microsurgery, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
出版信息
J Surg Oncol. 2017 Jan;115(1):96-98. doi: 10.1002/jso.24414. Epub 2016 Aug 26.
Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96-98. © 2016 Wiley Periodicals, Inc.
淋巴水肿是癌症治疗后常见的一种病症。该疾病的特征是进行性炎症过程，会导致不可逆的纤维化。其病程和疾病的进行性特征常常影响癌症幸存者的生活质量。淋巴水肿的病理生理学仍不清楚，且该疾病仍然无法治愈。在本文中，我们回顾了关于淋巴水肿的现有研究，并总结了淋巴水肿可能的治疗策略。《外科肿瘤学杂志》2017年；115：96 - 98。©2016威利期刊公司。
Zotero 插件